Baseline Ad5 serostatus does not predict Ad5 HIV vaccine–induced expansion of adenovirus-specific CD4+ T cells
- 20 July 2009
- journal article
- clinical trial
- Published by Springer Nature in Nature Medicine
- Vol. 15 (8) , 876-878
- https://doi.org/10.1038/nm.1989
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysisThe Lancet, 2008
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trialPublished by Elsevier ,2008
- Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade Bgag/pol/nefVaccine in Healthy AdultsClinical Infectious Diseases, 2008
- The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?The Journal of Experimental Medicine, 2008
- Quantitative Adenovirus Neutralization Assays Based on the Secreted Alkaline Phosphatase Reporter Gene: Application in Epidemiologic Studies and in the Design of Adenovector VaccinesHuman Gene Therapy, 2004
- A Replication-Defective Human Adenovirus Recombinant Serves as a Highly Efficacious Vaccine CarrierVirology, 1996
- Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humansNature, 1994
- Stable expression of rabies virus glycoprotein in Chinese hamster ovary cellsJournal of General Virology, 1991
- Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5Journal of General Virology, 1977